CIK 0000943819 · Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980152841
- Phone
- 8587462400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,744,605
- in 5 filings, $3.7M under 10b5-1 plans
Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-29 | Burt Carol Director | Gift | −234 | 14,939 | ||
| 2024-04-29 | Drexler Karen Director | Sale | −425 | $214.92 | $91K | 8,446 |
| 2024-03-04 | Rider Michael J Global General Counsel | Sale 10b5-1 | −81 | $180.00 | $15K | 6,607 |
| 2024-03-01 | Rider Michael J Global General Counsel | Sale 10b5-1 | −200 | $173.25 | $35K | 6,688 |
| 2024-02-22 | FARRELL PETER C Director | Sale | −10,935 | $182.66 | $2.0M | 157,404 |
| 2023-11-27 | Sandercock Brett Chief Financial Officer | Sale | −3,000 | $152.62 | $458K | 92,962 |
| 2023-11-22 | Rider Michael J Global General Counsel | Gift | −72 | 6,888 | ||
| 2023-11-20 | Farrell Michael J. Chief Executive Officer | Shares withheld for taxes | −2,352.93 | $148.94 | $350K | 440,752 |
| 2023-11-20 | Douglas Robert Andrew President and COO | Shares withheld for taxes | −1,375.22 | $148.94 | $205K | 13,849 |
| 2023-11-20 | Ghoshal Kaushik President, SaaS Business | Shares withheld for taxes | −366.97 | $148.94 | $55K | 12,908 |
| 2023-11-20 | Farrell Michael J. Chief Executive Officer | Shares withheld for taxes | −2,352.93 | $148.94 | $350K | 438,633 |
| 2023-11-16 | Burt Carol Director | Grant or award | +1,768 | 2,890 | ||
| 2023-11-16 | Farrell Michael J. Chief Executive Officer | Option exercise | +3,462 | $57.76 | $200K | 444,448 |
| 2023-11-16 | Farrell Michael J. Chief Executive Officer | Shares withheld for taxes | −1,343 | $148.90 | $200K | 443,105 |
| 2023-11-16 | Farrell Michael J. Chief Executive Officer | Option exercise · ResMed Common Stock Options | −3,462 | 0 | ||
| 2023-11-16 | Farrell Michael J. Chief Executive Officer | Grant or award · ResMed Common Stock Options | +55,468 | $148.90 | $8.3M | 55,468 |
| 2023-11-16 | SULPIZIO RICHARD Director | Grant or award | +1,768 | 16,713 | ||
| 2023-11-16 | De Witte Jan Director | Grant or award | +1,768 | 7,879 | ||
| 2023-11-16 | Hernandez John Director | Grant or award | +884 | 2,962 | ||
| 2023-11-16 | Hernandez John Director | Grant or award · ResMed Common Stock Options | +2,575 | $148.90 | $383K | 2,575 |
Page 16 of 18 · 360 trades